Zhang J, Li S, Zhang J, Zhang W, et al. Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway. Cancer Lett 2022 Jul 19:215829. doi: 10.1016/j.canlet.2022.215829.
PMID: 35868534